Latest filing published 17 Nov 2025 for TELA Bio, Inc., €3.4M.
Across 60 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of EW Healthcare Partners Fund 2, L.P. in TELA Bio, Inc. Between 1 April 2020 and 17 November 2025, the trades on record add up to 187 filings.
On the market, this insider has only ever bought: 187 purchases, €31.7M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 1 purchase and no sales.
The median purchase comes to €41k. As a share of market capitalisation, the median purchase stands at 0.12%, based on 3 purchases. On 37 out of 160 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 17 November 2025, reports an open-market purchase of €3.4M in TELA Bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 66 declarations